Roivant Sciences (ROIV) Profit After Tax (2020 - 2025)
Roivant Sciences (ROIV) posted Profit After Tax of -$753.7 million for Q4 2025, down 353.9% on a QoQ basis from -$166.0 million in Q3 2025, and down 544.94% year-over-year from $169.4 million in Q4 2024.
Roivant Sciences (ROIV) Profit After Tax (2020 - 2025) Analysis & Trends
Roivant Sciences' Profit After Tax history runs 6 years deep, the most recent figure standing at -$753.7 million for Q4 2025.
- Quarterly Profit After Tax fell 544.94% year-over-year to -$753.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$1.0 billion (down 120.08% YoY) and the FY2026 annual result came in at -$397.9 million, up 45.48% from the prior year.
- Profit After Tax was -$753.7 million for Q4 2025 at Roivant Sciences, down from -$166.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $5.2 billion in Q4 2023 and bottomed at -$1.1 billion in Q4 2022.
- A 5-year average of $37.7 million and a median of -$279.9 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2021 — Profit After Tax slumped 1167.12% — and 2023, when it soared 588.76%.
- Roivant Sciences' Profit After Tax stood at -$632.8 million in 2021, then sank by 66.66% to -$1.1 billion in 2022, then surged by 588.76% to $5.2 billion in 2023, then tumbled by 96.71% to $169.4 million in 2024, then tumbled by 544.94% to -$753.7 million in 2025.
- Business Quant data shows ROIV's Profit After Tax at -$753.7 million in Q4 2025, -$166.0 million in Q3 2025, and -$273.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Roivant Sciences | 24.27 Bn | 24.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -753.65 Mn |
| Sep 30, 2025 | -166.04 Mn |
| Jun 30, 2025 | -273.91 Mn |
| Dec 31, 2024 | 169.38 Mn |
| Sep 30, 2024 | -279.92 Mn |
| Jun 30, 2024 | 57.49 Mn |
| Dec 31, 2023 | 5.15 Bn |
| Sep 30, 2023 | -331.12 Mn |
| Jun 30, 2023 | -327.85 Mn |
| Dec 31, 2022 | -1.05 Bn |
| Sep 30, 2022 | -315.92 Mn |
| Jun 30, 2022 | -353.78 Mn |
| Dec 31, 2021 | -632.80 Mn |
| Sep 30, 2021 | -225.64 Mn |
| Jun 30, 2021 | -101.08 Mn |
| Dec 31, 2020 | -261.03 Mn |
| Sep 30, 2020 | -53.50 Mn |
| Jun 30, 2020 | -7.98 Mn |